SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mimedx Group, Inc. – ‘10-K’ for 12/31/21 – ‘EX-21.1’

On:  Monday, 2/28/22, at 5:11pm ET   ·   For:  12/31/21   ·   Accession #:  1376339-22-7   ·   File #:  1-35887

Previous ‘10-K’:  ‘10-K’ on 3/8/21 for 12/31/20   ·   Next:  ‘10-K’ on 2/28/23 for 12/31/22   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   26 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/28/22  Mimedx Group, Inc.                10-K       12/31/21  112:13M

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.42M 
 3: EX-10.38    Material Contract                                   HTML    739K 
 2: EX-10.6     Material Contract                                   HTML     40K 
 4: EX-21.1     Subsidiaries List                                   HTML     28K 
 5: EX-23.1     Consent of Expert or Counsel                        HTML     28K 
 6: EX-23.2     Consent of Expert or Counsel                        HTML     28K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     30K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     30K 
16: R1          Cover Page                                          HTML     92K 
17: R2          Audit Information                                   HTML     33K 
18: R3          Consolidated Balance Sheets                         HTML    137K 
19: R4          Consolidated Balance Sheets (Parenthetical)         HTML     62K 
20: R5          Consolidated Statements of Operations               HTML    114K 
21: R6          Consolidated Statements of Stockholders? Equity     HTML    101K 
                (Deficit)                                                        
22: R7          Consolidated Statements of Cash Flows               HTML    130K 
23: R8          Nature of Business                                  HTML     42K 
24: R9          Significant Accounting Policies                     HTML    109K 
25: R10         Accounts Receivable, Net                            HTML     36K 
26: R11         Inventory                                           HTML     38K 
27: R12         Property and Equipment                              HTML     52K 
28: R13         Leases                                              HTML    130K 
29: R14         Goodwill and Intangible Assets                      HTML     75K 
30: R15         Accrued Expenses                                    HTML     41K 
31: R16         Long Term Debt                                      HTML    100K 
32: R17         Net Loss Per Common Share                           HTML     71K 
33: R18         Equity                                              HTML    103K 
34: R19         Income Taxes                                        HTML    111K 
35: R20         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     47K 
                Investing and Financing Activities                               
36: R21         401(k) Plan                                         HTML     35K 
37: R22         Commitments and Contingencies                       HTML     48K 
38: R23         Revenue                                             HTML     53K 
39: R24         Related Party Transactions                          HTML     32K 
40: R25         Restructuring                                       HTML     39K 
41: R26         Subsequent Events                                   HTML     30K 
42: R27         Schedule II Valuation and Qualifying Accounts       HTML     52K 
43: R28         Significant Accounting Policies (Policies)          HTML    165K 
44: R29         Significant Accounting Policies (Tables)            HTML     54K 
45: R30         Accounts Receivable, Net (Tables)                   HTML     36K 
46: R31         Inventory (Tables)                                  HTML     38K 
47: R32         Property and Equipment (Tables)                     HTML     53K 
48: R33         Leases (Tables)                                     HTML     81K 
49: R34         Goodwill and Intangible Assets (Tables)             HTML    107K 
50: R35         Accrued Expenses (Tables)                           HTML     40K 
51: R36         Long Term Debt (Tables)                             HTML     80K 
52: R37         Basic and Diluted Net Loss Per Common Share         HTML     75K 
                (Tables)                                                         
53: R38         Equity (Tables)                                     HTML     96K 
54: R39         Income Taxes (Tables)                               HTML    108K 
55: R40         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     47K 
                Investing and Financing Activities (Tables)                      
56: R41         Commitments and Contingencies (Tables)              HTML     33K 
57: R42         Revenue (Tables)                                    HTML     66K 
58: R43         Restructuring (Tables)                              HTML     36K 
59: R44         Nature of Business (Details)                        HTML     62K 
60: R45         Significant Accounting Policies - Additional        HTML     65K 
                Information (Details)                                            
61: R46         Significant Accounting Policies - Transition        HTML     59K 
                Adjustment and Cash Collections on Remaining                     
                Contracts (Details)                                              
62: R47         Accounts Receivable, Net (Details)                  HTML     36K 
63: R48         Inventory (Details)                                 HTML     46K 
64: R49         Property and Equipment - Property and Equipment     HTML     52K 
                (Details)                                                        
65: R50         Property and Equipment - Depreciation (Details)     HTML     37K 
66: R51         Leases - Narrative (Details)                        HTML     34K 
67: R52         Leases - Supplemental Balance Sheet Information     HTML     72K 
                (Details)                                                        
68: R53         Leases - Lease Costs (Details)                      HTML     36K 
69: R54         Leases - Maturity of Lease Liabilities (Details)    HTML     86K 
70: R55         Goodwill and Intangible Assets - Narrative          HTML     33K 
                (Details)                                                        
71: R56         Goodwill and Intangible Assets - Changes in         HTML     33K 
                Carrying Amount of Goodwill (Details)                            
72: R57         Goodwill and Intangible Assets - Activity Summary   HTML     59K 
                (Details)                                                        
73: R58         Goodwill and Intangible Assets - Amortization       HTML     33K 
                Expense (Details)                                                
74: R59         Goodwill and Intangible Assets - Expected Future    HTML     44K 
                Amortization of Intangible Assets (Details)                      
75: R60         Accrued Expenses (Details)                          HTML     48K 
76: R61         Long Term Debt - Term Loan (Details)                HTML    127K 
77: R62         Long Term Debt - Term Loan Debt Issuance Costs      HTML     44K 
                (Details)                                                        
78: R63         Long Term Debt - Term Loan Balances (Details)       HTML     43K 
79: R64         Long Term Debt - Term Loan Interest Expense         HTML     52K 
                (Details)                                                        
80: R65         Long Term Debt - Term Loan Maturity (Details)       HTML     49K 
81: R66         Long Term Debt - Term Loan Extinguishment of Debt   HTML     44K 
                (Details)                                                        
82: R67         Basic and Diluted Net Loss Per Common Share -       HTML     64K 
                Basic Net Loss Per Common Share (Details)                        
83: R68         Basic and Diluted Net Loss Per Common Share -       HTML     63K 
                Diluted Net Loss Per Common Share (Details)                      
84: R69         Equity - Convertible Preferred Stock Series B       HTML     62K 
                (Details)                                                        
85: R70         Equity - Changes in Series B Preferred Stock        HTML     45K 
                (Details)                                                        
86: R71         Equity - Stock Incentive Plans (Details)            HTML     57K 
87: R72         Equity - Stock Option Activity (Details)            HTML     70K 
88: R73         Equity - Modification of Stock Options (Details)    HTML     63K 
89: R74         Equity - Restricted Stock Awards (Details)          HTML     57K 
90: R75         Equity - Summary of Restricted Stock Awards         HTML     65K 
                (Details)                                                        
91: R76         Equity - Recognized Stock-Based Compensation        HTML     42K 
                (Details)                                                        
92: R77         Equity - Treasury Stock (Details)                   HTML     37K 
93: R78         Income Taxes - Narrative (Details)                  HTML     74K 
94: R79         Income Taxes - Deferred Tax Assets and Liabilities  HTML     72K 
                (Details)                                                        
95: R80         Income Taxes - Reconciliation of the Federal        HTML     58K 
                Statutory Income Tax (Details)                                   
96: R81         Income Taxes - Schedule of current and deferred     HTML     51K 
                income tax expense (Benefit) (Details)                           
97: R82         Income Taxes - Reconciliation of unrecognized tax   HTML     36K 
                benefits (Details)                                               
98: R83         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     54K 
                Investing and Financing Activities (Details)                     
99: R84         401(k) Plan (Details)                               HTML     44K 
100: R85         Commitments and Contingencies - Narrative           HTML     40K  
                (Details)                                                        
101: R86         Commitments and Contingencies - Estimated Annual    HTML     35K  
                Lease, Royalty, and Employment Agreement Expenses                
                (Details)                                                        
102: R87         Revenue - Summary of Revenue by Product Type        HTML     48K  
                (Details)                                                        
103: R88         Revenue - Summary of Revenue by Customer Type       HTML     42K  
                (Details)                                                        
104: R89         Related Party Transactions (Details)                HTML     41K  
105: R90         Restructuring - Narrative (Details)                 HTML     35K  
106: R91         Restructuring - Restructuring Reserve Liability     HTML     36K  
                (Details)                                                        
107: R92         Schedule II Valuation and Qualifying Accounts       HTML     40K  
                (Details)                                                        
110: XML         IDEA XML File -- Filing Summary                      XML    197K  
108: XML         XBRL Instance -- mdxg-20211231_htm                   XML   2.72M  
109: EXCEL       IDEA Workbook of Financial Reports                  XLSX    143K  
12: EX-101.CAL  XBRL Calculations -- mdxg-20211231_cal               XML    333K 
13: EX-101.DEF  XBRL Definitions -- mdxg-20211231_def                XML    668K 
14: EX-101.LAB  XBRL Labels -- mdxg-20211231_lab                     XML   2.20M 
15: EX-101.PRE  XBRL Presentations -- mdxg-20211231_pre              XML   1.31M 
11: EX-101.SCH  XBRL Schema -- mdxg-20211231                         XSD    216K 
111: JSON        XBRL Instance as JSON Data -- MetaLinks              524±   749K  
112: ZIP         XBRL Zipped Folder -- 0001376339-22-000007-xbrl      Zip    653K  


‘EX-21.1’   —   Subsidiaries List


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 21.1
MiMedx Group, Inc.
List of Subsidiaries
CompanyJurisdiction of Organization
MiMedx Tissue Services, LLCGeorgia
MiMedx Processing Services, LLCFlorida



4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Mimedx Group, Inc.                10-K       12/31/23  116:11M
 2/28/23  Mimedx Group, Inc.                10-K       12/31/22  123:13M
 6/17/22  Mimedx Group, Inc.                S-8         6/17/22    5:85K                                    Donnelley … Solutions/FA
 5/03/22  Mimedx Group, Inc.                10-Q        3/31/22   71:5.5M


22 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/03/21  Mimedx Group, Inc.                10-Q        6/30/21   77:7.4M
 6/10/21  Mimedx Group, Inc.                8-K:5,9     6/09/21   12:193K
 6/03/21  Mimedx Group, Inc.                8-K:5,9     5/27/21   11:244K
 4/21/21  Mimedx Group, Inc.                8-K:5,9     4/19/21   12:465K                                   Donnelley … Solutions/FA
 3/30/21  Mimedx Group, Inc.                8-K:4,9     3/25/21   13:178K
 3/08/21  Mimedx Group, Inc.                10-K       12/31/20  111:12M
12/21/20  Mimedx Group, Inc.                8-K:5      12/16/20   14:372K
12/17/20  Mimedx Group, Inc.                S-8        12/17/20    5:422K                                   Donnelley … Solutions/FA
11/04/20  Mimedx Group, Inc.                10-Q        9/30/20   79:7.4M
11/02/20  Mimedx Group, Inc.                8-A12B                 1:37K
 7/06/20  Mimedx Group, Inc.                10-K       12/31/19  119:16M
 3/17/20  Mimedx Group, Inc.                10-K       12/31/18  111:16M
 5/30/19  Mimedx Group, Inc.                8-K:8,9     5/30/19   11:511K                                   Donnelley … Solutions/FA
 5/09/19  Mimedx Group, Inc.                8-K:5,7,9   5/06/19    3:112K                                   Donnelley … Solutions/FA
 3/13/17  Mimedx Group, Inc.                8-K:1,2,9   3/07/17    2:81K
 8/02/16  Mimedx Group, Inc.                10-Q        6/30/16   72:5.6M
 3/04/14  Mimedx Group, Inc.                10-K       12/31/13   81:10M
 3/03/14  Mimedx Group, Inc.                8-K:1,5,9   2/25/14    3:187K                                   Broadridge Fin’l So… Inc
 8/08/13  Mimedx Group, Inc.                10-Q        6/30/13  104:10M
 5/10/13  Mimedx Group, Inc.                10-Q        3/31/13   60:6M                                     Broadridge Fin’l So… Inc
 7/15/08  Mimedx Group, Inc.                8-K:1,5,9   7/09/08    3:85K                                    Bowne - BPC/FA
 2/08/08  Mimedx Group, Inc.                8-K:1,2,3,4 2/08/08   63:3.9M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001376339-22-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 4, 6:07:02.3pm ET